MHRA Drug Safety Update June 2019

MHRA Drug Safety Update June 2019

June 20, 2019

Date issued: 19th June 2019

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 11 June 2019:1) has been published and includes articles on:

  • Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome
  • GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued
  • Lartruvo▼ (olaratumab): withdrawal of the EU marketing authorisation due to lack of efficacy
  • Oral retinoid medicines▼: revised and simplified pregnancy prevention educational materials for healthcare professionals and women
  • Letters and drug alerts sent to healthcare professionals in May 2019
  • Medical Device Alerts issued in April 2019

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...